Medtronic (MDT) Tops Q1 EPS by 9c; Offers FY23 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $105.40 +6.59%
EPS Growth %: -2.2%
Financial Fact:
Other expense, net: 24M
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: -2.2%
Financial Fact:
Other expense, net: 24M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q1 EPS of $1.20, $0.09 better than the analyst estimate of $1.11. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.57 billion.
GUIDANCE:
Medtronic sees FY2024 EPS of $5.08-$5.16, versus the consensus of $5.05.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
